Dubai, UAE: Dubai Investments has completed the acquisition of the remaining 80% stake in Clemenceau Medical Centre Dubai (CMC Dubai), increasing its ownership from 20% to 100%. The transaction, executed through Dubai Investments Industries, positions CMC Dubai as a wholly owned subsidiary of the Group and reinforces Dubai Investments’ long-term commitment to the healthcare sector.
The acquisition represents a strategic milestone in the Group’s investment approach, focusing on increasing ownership in high-performing businesses operating within sectors that demonstrate sustainable long-term growth potential.
Commenting on the acquisition, Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, said:
“The acquisition of 100% ownership of Clemenceau Medical Centre Dubai reflects the Group’s conviction in the long-term growth potential of the healthcare sector and the strategy of increasing ownership in high-quality businesses where the Group can create greater value through active stewardship and long-term investment.”
He added that full ownership provides Dubai Investments with greater strategic and operational flexibility, enabling the Group to accelerate CMC Dubai’s expansion plans, strengthen its portfolio of specialized healthcare services, and fully capitalize on future growth opportunities.
Bin Kalban further emphasized that the Group will continue investing in advanced capabilities that enhance patient outcomes, operational excellence, and long-term competitiveness, reinforcing CMC Dubai’s position as a leading healthcare provider within the UAE while delivering sustainable value to shareholders.
Located in Dubai Healthcare City, Clemenceau Medical Centre Dubai has established itself as one of the UAE’s premier tertiary care hospitals. Since commencing operations in 2020, the hospital has gained recognition for delivering advanced medical care through internationally trained physicians, cutting-edge medical technologies, and a patient-centric model of care.
Over the past five years, CMC Dubai has built a strong reputation for clinical excellence, complex medical procedures, and specialized treatment services, serving an expanding patient population from the United Arab Emirates, the Gulf Cooperation Council (GCC) region, and international markets.
The acquisition underscores the growing confidence of regional investment groups in the UAE’s healthcare industry, where increasing demand for specialized medical services, advanced clinical capabilities, and world-class patient care continues to create attractive long-term investment opportunities.
